Concepedia

Frédérique Bard

FB

Statistics

Publications

28

Citations

4.7K

H-Index

24

Active since

1989

Affiliations

Sunesis (United States)(Current)

Janssen (United States)

Johnson & Johnson (United States)

Harvard University

Janssen (Netherlands)

Frédérique Bard is an author at Sunesis (United States) specializing in life sciences, neurodegenerative diseases, and neurodegenerative disorders.

Publications per year

1989–2019

28

Publications

28

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Frédérique Bard, Catherine Cannon, Robin Barbour et al. · Nature Medicine · 2000 · 2K citations

, , +17

Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology

Frédérique Bard, Robin Barbour, Catherine Cannon et al. · Proceedings of the National Academy of Sciences · 2003 · 407 citations

, , +17

Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

Eliezer Masliah, Laura Hansen, Anthony Adame et al. · Neurology · 2005 · 352 citations

, , +17

Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer’s pathology

Ina Tesseur, Kun Zou, Luke Esposito et al. · Journal of Clinical Investigation · 2006 · 351 citations · Full text

, , +17

Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System

Kelly J. Inglis, David Chéreau, Elizabeth Brigham et al. · Journal of Biological Chemistry · 2008 · 270 citations · Full text

, , +10

1–5 of 28